Anthony Coates
9Patents
3h-index
15Co-inventors
50Inventor score
Filing activity: Nov 5, 2003 → Apr 12, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9085632B2 | Biological materials and uses thereof | Emerging Cross-Sectional Technologies | 16 | Active |
| US8207187B2 | Use of pyrroloquinoline compounds to kill clinically latent microorganisms | Emerging Cross-Sectional Technologies | 13 | Active |
| US7744906B2 | Pain relief agents | Emerging Cross-Sectional Technologies | 9 | Expired |
| US8940723B2 | Combination of a pyrroloquinoline compound and a beta-lactam antimicrobial agent, mupirocin or chlorhexidine | Emerging Cross-Sectional Technologies | 2 | Active |
| US9549965B2 | Pharmaceutical composition for treating a microbial infection | Emerging Cross-Sectional Technologies | 1 | Active |
| US7892782B2 | Screening process for antibacterial agents | Human Necessities | 0 | Active |
| US9320791B2 | Peptides from chaperonin 60.1 | Emerging Cross-Sectional Technologies | 0 | Active |
| US8759348B2 | Use of 4-(pyrrolidin-1-yl)quinoline compounds to kill clinically latent microorganisms | Emerging Cross-Sectional Technologies | 0 | Active |
| US11951119B2 | Combination comprising zidovudine and an antimicrobial compound | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.